USPTO serial 78091167
SPIN SIGNAL
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- HARDY LUDLOW, TARAH KIM
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SPIN SIGNAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Little Chalfont, Buckinghamshire, GB
Little Chalfont, Buckinghamshire, GB
BUCKINGHAMSHIRE, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Catherine Mennenga
CATHERINE MENNENGA GENERAL ELECTRIC COMPANY3135 EASTON TPKEFAIRFIELD, CT 06828-0001UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals, biochemicals and reagents for use in industry, science, and research, namely, nucleotides, fluorescent nucleotides, oligonucleotides, peptides, proteins, amino acids, organic molecules, chemical markers for DNA and RNA synthesis; reagents for luminescence; reagents for gene expression quantification; reagents for use with the polymerase reaction, PCR, process and RCA, rolling circle amplication process; reagents for cDNA cloning vectors, modifying and restriction enzymes; reagents for labeling, sequencing and fragment analysis of nucleic acids, proteins and custom synthesis; reagents for recombinant protein expression purification, chromatography media, electrophoresis, spectrophotometry and fluorometry; radiochemicals; scintillation assays; and high through put screening assays for drug development; chemical preparations and substances for use in the manufacture of pharmaceutical products; diagnostic preparations and substances for scientific and research use; chemical test reagents, saline solution and reagent-coated paper all for scientific and laboratory use; fissionable chemical elements; radioactive elements, isotopes, preparations, and reagents for industrial, scientific, and research purposes; kits consisting primarily of chemical preparations and reagents for analysis and diagnosis used for scientific purposes, namely, cell separation and culture, nucleic acid purification; radionuclides; and gases and gas mixtures for industrial, scientific, and research purposes | ACTIVE | — |
| 005 | Contrast media for medical imaging; diagnostic scanning agents, gases and gas mixtures for medical imaging, and reagents for in vivo clinical use; radiopharmaceutical products, namely, radioactive compounds for use in diagnostic imaging for clinical, medical, scientific, and research use; radioactive sources and standards, namely, radioisotope brachytherapy sources and radioactive compounds for use as calibration standards for use in nuclear medicine; radioactive pharmaceutical preparations and non-radioactive reagents for producing radiopharmaceuticals for in vivo diagnostic and therapeutic use; pharmaceutical preparations, namely, reagents for use in medical diagnosis; pre-filled vials containing medical diagnostic reagents; pre-filled cartridges containing saline solution | ACTIVE | — |
| 009 | Scientific apparatus and instruments for use in measuring, monitoring and surveying, namely, computers, printers, and computer software programs for use in life science research and data analysis, namely, detecting and monitoring radiation, radioactivity, and radioactive contamination, and for nuclear cardiology and medical imaging, for use by laboratories; radiology apparatus and instruments for the reading and interpretation of autoradiographs and films, namely, automated film readers and scanners; apparatus for electrophoresis comprised of gel separation units, power/control units, gel cassettes, tanks, and casting, running and blotting modules; chromatography columns and pumps; scientific apparatus for microfabrication comprised of scanners and imagers; apparatus for scintillation imaging cameras and scintillation counters; synthesis and purification integrated systems comprised of chromatography monitors, computer hardware and data processing software for use in radiology; imaging apparatus for radioactive and luminescent emissions for use in radiology; imaging apparatus for radioactive and luminescent emissions for use in radiology; apparatus for use in the manufacturing of oligonucleotides, comprised of synthesizers and purifiers; apparatus for microarrays, comprised of array spotters, array scanners, slide processors and hybridation buffers; microarray slides; glassware, namely, glass tubes, vials, microvials, and microplates for scientific purposes; and parts and fittings for the aforesaid goods; diagnostic and test kits for medical use comprised of test tubes, test plates and indicator charts for evaluating test results | ACTIVE | — |
| 010 | Surgical, medical, dental, and veterinary apparatus and instruments used for the purpose of measuring, monitoring and surveying in the field of radiotherapy, namely, medical needles, suture needles, implantable radiation therapy devices and implantable radiation therapy devices consisting of encapsulated radioisotope brachytherapy sources, radiation therapy delivery system consisting primarily of radioactive seeds and a bio-absorbable carrier assembly; radiological apparatus for diagnostic and medical purposes, namely, magnetic resonance imagers, MRI; x-ray apparatus for medical use; x-ray diagnostic apparatus, computerized tomography apparatus, CAT scan apparatus; scanners and ultrasound diagnostic apparatus; cannulas; vial access cannulas; needles and syringes for medical use; injectors for medical use; cartridges for medical use; infusion pumps for intravenous administration of fluids; imaging apparatus for radioactive and luminescent emissions for use in radiology; and parts and fittings for the aforesaid goods | ACTIVE | — |
| 041 | Educational services, namely training services and conducting classes and seminars in the field of medical imaging and diagnostics; holding seminars, conferences, symposiums and workshops relating to the pharmaceutical industry, for medical practitioners and employees of pharmaceutical companies. | ACTIVE | — |
| 042 | Pharmaceutical advice, consultancy, and analytical services relating to chemical and pharmaceutical research for pharmaceutical companies in the field of purification and chromatography; development services in the fields of pharmaceuticals, life sciences, medicine and biochemistry; product research and development for others, namely research and development of pharmaceutical, medical, and veterinary preparations, diagnostic media and agents for use in medical and diagnostic imaging; providing medical information and medicinal information, namely, information regarding pharmacological properties to pharmaceutical companies and medical professionals; medical laboratory services, namely, medical diagnostic services, and medical imaging services; radiolabeling services, namely isotopic labeling of biological molecules; pharmaceutical drug development services for pharmaceutical companies and medical professionals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Amersham PLC
- Other trademarks owned by Amersham PLC
- Other trademarks owned by GE HEALTHCARE LIMITED
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named SPIN SIGNAL
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 17, 2006 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 17, 2006 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 19, 2005 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Sep 12, 2005 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 12, 2005 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 11, 2005 | EXT5 | SOU EXTENSION 5 FILED | — |
| Apr 4, 2005 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Mar 8, 2005 | EXT4 | SOU EXTENSION 4 FILED | — |
| Mar 8, 2005 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 17, 2005 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 17, 2005 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 23, 2004 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Sep 13, 2004 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 11, 2004 | EXT3 | SOU EXTENSION 3 FILED | — |
| Aug 24, 2004 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 11, 2004 | CFIT | CASE FILE IN TICRS | — |
| Feb 4, 2004 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 12, 2004 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 12, 2004 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 22, 2003 | PAPER RECEIVED | — | |
| Sep 2, 2003 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 7, 2003 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 7, 2003 | PAPER RECEIVED | — | |
| Apr 1, 2003 | PAPER RECEIVED | — | |
| Mar 11, 2003 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 18, 2002 | PAPER RECEIVED | — | |
| Dec 17, 2002 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 27, 2002 | NPUB | NOTICE OF PUBLICATION | — |
| Oct 17, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 17, 2002 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 15, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 15, 2002 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Aug 9, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 15, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 15, 2002 | PAPER RECEIVED | — | |
| May 17, 2002 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 5, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 5, 2002 | PAPER RECEIVED | — | |
| Feb 9, 2002 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 30, 2002 | DOCK | ASSIGNED TO EXAMINER | — |